| [1] |
Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.
Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer
[J]. Journal of International Oncology, 2024, 51(6): 332-337.
|
| [2] |
Liu Jing, Liu Qin, Huang Mei.
Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm
[J]. Journal of International Oncology, 2024, 51(5): 267-273.
|
| [3] |
Wan Fang, Yang Gang, Li Rui, Wan Qijing.
Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer
[J]. Journal of International Oncology, 2024, 51(4): 204-209.
|
| [4] |
Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.
Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients
[J]. Journal of International Oncology, 2024, 51(1): 37-42.
|
| [5] |
Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer.
Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma （2023 Edition）
[J]. Journal of International Oncology, 2023, 50(7): 385-397.
|
| [6] |
Ji Shiyu, Zhang Mingxin, Xie Huahong, Bai Yuan, Wang Tong.
Observation on the efficacy of different stents in the treatment of patients with advanced esophageal cancer
[J]. Journal of International Oncology, 2023, 50(2): 76-81.
|
| [7] |
Gong Heyi, Yi Yan, Zhang Jian, Li Baosheng.
Management strategies for locally advanced operable esophageal carcinoma achieving clinical complete response after neoadjuvant chemoradiotherapy
[J]. Journal of International Oncology, 2023, 50(12): 745-750.
|
| [8] |
Deng Lili, Duan Xingyu, Li Baozhong.
Advances of anti-HER2 targeted drugs and combined therapeutic regimens for gastric and esophagogastic adenocarcinoma
[J]. Journal of International Oncology, 2023, 50(12): 751-757.
|
| [9] |
Xie Yu, Zheng Shengnan, Huang Mingmin, Guo Aibin, Yin Zhenyu, Lin Yongjuan.
Pemetrexed clinical trial for intrathecal injection chemotherapy based on cerebrospinal fluid pharmacokinetics in patients with leptomeningeal metastasis from lung adenocarcinoma
[J]. Journal of International Oncology, 2023, 50(10): 585-591.
|
| [10] |
Wu Puyuan, Qi Liang, Wang Tao, Shi Minke, Sun Yuwei, Wang Lifeng, Liu Baorui, Yan Jing, Ren Wei.
Efficacy of postoperative radiotherapy based on modified clinical target volume according to high-frequency recurrence regions in patients with esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2022, 49(8): 464-472.
|
| [11] |
Lin Yongjuan, Li Huiying, Yin Zhenyu, Guo Aibin, Xie Yu.
Investigation of cerebrospinal fluid metabolites in patients with leptomeningeal metastases from lung adenocarcinoma based on untargeted metabolomics
[J]. Journal of International Oncology, 2022, 49(7): 390-399.
|
| [12] |
Xia Lingling, Chen Yongshun, Li Bin, Ning Tingting, Zhang Caiyutian.
Comparison of safety and efficacy between chemoradiotherapy and chemotherapy after R0 resection in pN+ esophageal squamous cell carcinoma patients
[J]. Journal of International Oncology, 2022, 49(6): 334-339.
|
| [13] |
Ye Qian, Ling Zhi, Liu Shenxiang, Lu Guotao, Yin Xudong.
Effects of sarcopenia on the clinical efficacy and prognosis of radical radiotherapy in elderly patients with esophageal cancer
[J]. Journal of International Oncology, 2022, 49(4): 199-205.
|
| [14] |
Zhou Jianfeng, Wang Tiejun.
Targeted therapy and immunotherapy of esophageal cancer
[J]. Journal of International Oncology, 2022, 49(4): 237-242.
|
| [15] |
Liu Jia, Ge Xiaolin, Di Xiaoke, Shi Yujing, Zeng Yuting.
Efficacy analysis of Xiyanping injection on prevention of radioactive esophagitis
[J]. Journal of International Oncology, 2022, 49(3): 146-150.
|
